Comparator: Pbo
ApprovedSmall molecule
Merck & Co.Comparator: Pbo is one of 1028 small molecule programs targeting Coronary Artery Disease. It is currently in Approved.
40
Indications
174
Total Trials
0
Active Trials
1,027
Competitors
Pipeline
Status by Indication[3][1]
Indication
Showing 10 of 40 indications
Competition
Competitive Landscape
2828 competitors in Breast Cancer
#DrugCompanyPhaseTrials
1Comparator: Pbo
Merck & Co.Approved
Prolia
AmgenPreclinical
MS Contin
HHikma Pharmaceuticals LLC
Preclinical
Methylthioninium Chloride
PProvepharm SAS
Preclinical
Chirocaine
PPurdue Pharma LP
Preclinical
Cortef
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Zoladex
Luye Pharma Group Ltd.Preclinical
Metfomin
UUniversity of Texas Southwestern Medical Center
Preclinical
Lipegfilgrastim
Merck & Co.Preclinical
Iniparib
SanofiPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Type 2 Diabetes Mellitus16 trials
Show 13 more trials
Vaccine6 trials
Show 3 more trials
Type 2 Diabetes6 trials
Nausea and vomiting5 trials
Treatment4 trials
90 more indications
Safety and Efficacy4 trials
Hepatitis B4 trials
Immunogenicity4 trials
TED3 trials
Non-Small Cell Lung Cancer3 trials
Hypertension3 trials
Major Depressive Disorder3 trials
Papilloma3 trials
Children3 trials
Insulin Secretion3 trials
Lip2 trials
Cutaneous T-cell lymphoma2 trials
Diphtheria2 trials
Dental Pain2 trials
Metformin2 trials
HPV Vaccine2 trials
Ocular Hypertension2 trials
Overweight2 trials
Cholesterol2 trials
Atorvastatin2 trials
Postmenopausal Women2 trials
Asthma2 trials
Hypercholesterolemia2 trials
Patients With Advanced Solid Tumors2 trials
Urinary Tract Infection2 trials
Single Dose2 trials
Tics2 trials
Biomarkers2 trials
Complicated Intra-abdominal Infections2 trials
Advanced Cancer1 trial
Bone Metastasis1 trial
Testosterone1 trial
Hepatitis C1 trial
Post Operative Pain1 trial
Breast Cancer1 trial
Chemotherapy1 trial
Aspergillosis1 trial
Diabetic Neuropathy1 trial
Infections1 trial
Chronic Hepatitis1 trial
PrEP1 trial
Hepatitis C Virus Infection1 trial
Ischemic stroke1 trial
Heart1 trial
Poliomyelitis1 trial
Ondansetron1 trial
Varicella Zoster1 trial
Chemotherapy-induced nausea and vomiting1 trial
Methicillin-resistant Staphylococcus Aureus1 trial
Concentration1 trial
Pediatric Patients1 trial
First Line Therapy1 trial
Pneumonia1 trial
Pediatric1 trial
Hyperlipidemia1 trial
Chronic Kidney Disease1 trial
Dyslipidemia1 trial
Coronary Artery Disease1 trial
Intra-abdominal Infections1 trial
Rheumatoid Arthritis1 trial
Schizophrenia1 trial
Prostate Cancer1 trial
NAC1 trial
Surgical Site Infection1 trial
Immunodeficiency1 trial
Sarcopenia1 trial
Proteinuria1 trial
Immune Response1 trial
Hepatitis1 trial
Antiplatelet1 trial
Obstructive Sleep Apnea1 trial
Antibody Response1 trial
Unspecified6 trials
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Comparator: Pbo. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company